$4.2B deal: GSK and Merck KGaA to develop cancer immunotherapy By: Philadelphia Business Journal via Business Journals February 05, 2019 at 11:01 AM EST The deal includes a $343 million upfront payment payment and potential future milestone payments of nearly $3.9 billion. Read More >>
